Progress in low dose health risk research

Abstract

People are more often exposed to low as opposed to high doses of ionising radiation (IR). Knowledge on the health risks associated with exposures to ionising radiation above 100 mGy is quite well established, while lower dose risks are inferred from higher level exposure information (ICRP). The health risk assessments are mainly based on epidemiological data derived from the atomic bombing of Hiroshima and Nagasaki, medical exposure studies and follow-up studies after nuclear accidents. For the estimation of long-term stochastic radiation health effects (such as cancer) and radiation protection purposes, a linear non-threshold (LNT) model is applied. However, the general validity of the LNT hypothesis for extrapolations from effects of high to low doses (<100 mGy) and low dose-rates (<6 mGy/h) has been questioned as epidemiological studies are statistically limited at low doses and unable to evaluate low dose and low dose-rate health risks (UNSCEAR). Thus, uncertainties on health risks need to be clarified with the help of mechanistic studies. The European Network of Excellence DoReMi (2010-2016) was designed to address some of the existing uncertainties and to identify research lines that are likely to be most informative for low dose risk assessment. The present review reports the results obtained from studies addressing the induction of cancer and non-cancer effects by low dose IR as well as on individual radiation sensitivity. It is shown that low dose and low dose-rate effects are the result of complex network responses including genetic, epigenetic, metabolic and immunological regulation. Evidence is provided for the existence of nonlinear biological responses in the low and medium dose range as well as effects other than the classical DNA damage. Such effects may have a bearing on the quantitative and qualitative judgements on health effects induced by low dose radiations.

Mesenchymal stem cell-derived extracellular vesicles as probable triggers of radiation-induced heart disease

“…Second, hp-MSCs were exposed to only 5 Gy at a high dose rate (1 Gy/min) which is equivalent to the daily dose generally used in clinical radiotherapy for cancers. As the biological effects on cells vary greatly depending on the dose and dose rate of radiation [ 50 , 51 ], it is necessary to evaluate the quantity and quality of EVs from MSCs by exposing the cells to different doses and dose rates of radiation. Third, we analyzed only miRNAs, but radiation exposure may also change other components such as lipids, proteins, and lncRNAs in EVs.…”

The Effect of Low Temperatures on Environmental Radiation Damage in Living Systems: Does Hypothermia Show Promise for Space Travel?

“…The quality and quantity of DNA damage is assessed in terms of the radiation type and dose [ 28 ]. For example, high and low linear energy transfer (LET) radiation induce different spectra and qualities/complexity of DNA lesions, because of the differences in radiation track structures [ 29 ].…”

Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review

“…Radiosensitivity is any enhanced tissue or cell reaction after a subject has been exposed to IR when compared to the majority of other "normal" responding individuals [13,14]. The reactions include inflammation, fibrosis, cardiovascular illness, cataracts, and cognitive decline [15]. Individual radiosensitivity can be applied as component of personalized medicine in RT.…”